Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious program, conolidine modulates alternate molecular targets. A Science Advancements review identified that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://campbellu792ynh5.blue-blogs.com/profile